Cargando…
Incidence and risk factors of severe non‐proliferative/proliferative diabetic retinopathy: More than a decade follow up in the Tehran Lipids and Glucose Study
AIMS/INTRODUCTION: To examine the incidence rate of severe non‐proliferative and proliferative diabetic retinopathy (severe‐NPDR/PDR) and determine its potential risk factors. MATERIALS AND METHODS: The study consisted of 1,169 participants (675 women) with type 2 diabetes mellitus, aged ≥20 years....
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847124/ https://www.ncbi.nlm.nih.gov/pubmed/34403198 http://dx.doi.org/10.1111/jdi.13647 |
_version_ | 1784651982829518848 |
---|---|
author | Sardarinia, Mahsa Asgari, Samaneh Hizomi Arani, Reyhane Eskandari, Fatemeh Azizi, Fereidoun Khalili, Davood Hadaegh, Farzad |
author_facet | Sardarinia, Mahsa Asgari, Samaneh Hizomi Arani, Reyhane Eskandari, Fatemeh Azizi, Fereidoun Khalili, Davood Hadaegh, Farzad |
author_sort | Sardarinia, Mahsa |
collection | PubMed |
description | AIMS/INTRODUCTION: To examine the incidence rate of severe non‐proliferative and proliferative diabetic retinopathy (severe‐NPDR/PDR) and determine its potential risk factors. MATERIALS AND METHODS: The study consisted of 1,169 participants (675 women) with type 2 diabetes mellitus, aged ≥20 years. A trained interviewer collected information about the history of pan‐retinal photocoagulation as a result of diabetic retinopathy. Multivariable Cox proportional hazards regression models were applied. RESULTS: We found 187 cases (126 women) of severe‐NPDR/PDR during a median follow‐up period of 12.7 years; the corresponding incidence rate was 13.6 per 1,000 person‐years. Being overweight (hazard ratio [HR], 95% confidence interval [CI] 0.60, 0.39–0.92) and obese (HR 0.48, 95% CI 0.27–0.83) were associated with lower risk, whereas being smoker (HR 1.75, 95% CI 1.12–2.74), having fasting plasma glucose levels 7.22–10.0 mmol/L (HR 2.81, 95% CI 1.70–4.62), fasting plasma glucose ≥10 mmol/L (HR 5.87, 95% CI 3.67–9.41), taking glucose‐lowering medications (HR 2.58, 95% CI 1.87–3.56), prehypertension status (HR 1.65, 95% CI 1.05–2.58) and newly diagnosed hypertension (HR 1.96, 95% CI 1.06–3.65) increased the risk of severe‐NPDR/PDR. Among newly diagnosed diabetes patients, being male was associated with a 59% lower risk of severe‐NPDR/PDR (HR 0.41, 95% CI 0.21–0.79). Furthermore, patients who had an intermediate level of education (6–12 years) had a higher risk of developing PDR (HR 1.86, 95% CI 1.05–3.30) compared with those who had <6 years of education. CONCLUSIONS: Among Iranians with type 2 diabetes mellitus, 1.36% developed severe‐NPDR/PDR annually. Normal bodyweight, being a smoker, out of target fasting plasma glucose level, prehypertension and newly diagnosed hypertension status were independent risk factors of severe‐NPDR/PDR. Regarding the sight‐threatening entity of advanced diabetic retinopathy, the multicomponent strategy to control diabetes, abstinence of smoking and tight control of blood pressure should be considered. |
format | Online Article Text |
id | pubmed-8847124 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88471242022-02-25 Incidence and risk factors of severe non‐proliferative/proliferative diabetic retinopathy: More than a decade follow up in the Tehran Lipids and Glucose Study Sardarinia, Mahsa Asgari, Samaneh Hizomi Arani, Reyhane Eskandari, Fatemeh Azizi, Fereidoun Khalili, Davood Hadaegh, Farzad J Diabetes Investig Original Articles AIMS/INTRODUCTION: To examine the incidence rate of severe non‐proliferative and proliferative diabetic retinopathy (severe‐NPDR/PDR) and determine its potential risk factors. MATERIALS AND METHODS: The study consisted of 1,169 participants (675 women) with type 2 diabetes mellitus, aged ≥20 years. A trained interviewer collected information about the history of pan‐retinal photocoagulation as a result of diabetic retinopathy. Multivariable Cox proportional hazards regression models were applied. RESULTS: We found 187 cases (126 women) of severe‐NPDR/PDR during a median follow‐up period of 12.7 years; the corresponding incidence rate was 13.6 per 1,000 person‐years. Being overweight (hazard ratio [HR], 95% confidence interval [CI] 0.60, 0.39–0.92) and obese (HR 0.48, 95% CI 0.27–0.83) were associated with lower risk, whereas being smoker (HR 1.75, 95% CI 1.12–2.74), having fasting plasma glucose levels 7.22–10.0 mmol/L (HR 2.81, 95% CI 1.70–4.62), fasting plasma glucose ≥10 mmol/L (HR 5.87, 95% CI 3.67–9.41), taking glucose‐lowering medications (HR 2.58, 95% CI 1.87–3.56), prehypertension status (HR 1.65, 95% CI 1.05–2.58) and newly diagnosed hypertension (HR 1.96, 95% CI 1.06–3.65) increased the risk of severe‐NPDR/PDR. Among newly diagnosed diabetes patients, being male was associated with a 59% lower risk of severe‐NPDR/PDR (HR 0.41, 95% CI 0.21–0.79). Furthermore, patients who had an intermediate level of education (6–12 years) had a higher risk of developing PDR (HR 1.86, 95% CI 1.05–3.30) compared with those who had <6 years of education. CONCLUSIONS: Among Iranians with type 2 diabetes mellitus, 1.36% developed severe‐NPDR/PDR annually. Normal bodyweight, being a smoker, out of target fasting plasma glucose level, prehypertension and newly diagnosed hypertension status were independent risk factors of severe‐NPDR/PDR. Regarding the sight‐threatening entity of advanced diabetic retinopathy, the multicomponent strategy to control diabetes, abstinence of smoking and tight control of blood pressure should be considered. John Wiley and Sons Inc. 2021-09-13 2022-02 /pmc/articles/PMC8847124/ /pubmed/34403198 http://dx.doi.org/10.1111/jdi.13647 Text en © 2021 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Articles Sardarinia, Mahsa Asgari, Samaneh Hizomi Arani, Reyhane Eskandari, Fatemeh Azizi, Fereidoun Khalili, Davood Hadaegh, Farzad Incidence and risk factors of severe non‐proliferative/proliferative diabetic retinopathy: More than a decade follow up in the Tehran Lipids and Glucose Study |
title | Incidence and risk factors of severe non‐proliferative/proliferative diabetic retinopathy: More than a decade follow up in the Tehran Lipids and Glucose Study |
title_full | Incidence and risk factors of severe non‐proliferative/proliferative diabetic retinopathy: More than a decade follow up in the Tehran Lipids and Glucose Study |
title_fullStr | Incidence and risk factors of severe non‐proliferative/proliferative diabetic retinopathy: More than a decade follow up in the Tehran Lipids and Glucose Study |
title_full_unstemmed | Incidence and risk factors of severe non‐proliferative/proliferative diabetic retinopathy: More than a decade follow up in the Tehran Lipids and Glucose Study |
title_short | Incidence and risk factors of severe non‐proliferative/proliferative diabetic retinopathy: More than a decade follow up in the Tehran Lipids and Glucose Study |
title_sort | incidence and risk factors of severe non‐proliferative/proliferative diabetic retinopathy: more than a decade follow up in the tehran lipids and glucose study |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847124/ https://www.ncbi.nlm.nih.gov/pubmed/34403198 http://dx.doi.org/10.1111/jdi.13647 |
work_keys_str_mv | AT sardariniamahsa incidenceandriskfactorsofseverenonproliferativeproliferativediabeticretinopathymorethanadecadefollowupinthetehranlipidsandglucosestudy AT asgarisamaneh incidenceandriskfactorsofseverenonproliferativeproliferativediabeticretinopathymorethanadecadefollowupinthetehranlipidsandglucosestudy AT hizomiaranireyhane incidenceandriskfactorsofseverenonproliferativeproliferativediabeticretinopathymorethanadecadefollowupinthetehranlipidsandglucosestudy AT eskandarifatemeh incidenceandriskfactorsofseverenonproliferativeproliferativediabeticretinopathymorethanadecadefollowupinthetehranlipidsandglucosestudy AT azizifereidoun incidenceandriskfactorsofseverenonproliferativeproliferativediabeticretinopathymorethanadecadefollowupinthetehranlipidsandglucosestudy AT khalilidavood incidenceandriskfactorsofseverenonproliferativeproliferativediabeticretinopathymorethanadecadefollowupinthetehranlipidsandglucosestudy AT hadaeghfarzad incidenceandriskfactorsofseverenonproliferativeproliferativediabeticretinopathymorethanadecadefollowupinthetehranlipidsandglucosestudy |